RIA
GMAB icon

Regal Investment Advisors’s Genmab GMAB Stock Holding History

Regal Investment Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,863
Closed -$205K – 585
2024
Q1 		$205K Buy
6,863
+515
+8% +$15.1K 0.01% 547
2023
Q4 		$202K Buy
+6,348
New +$199K 0.02% 514
2023
Q1 		– Sell
-5,738
Closed -$243K – 530
2022
Q4 		$243K Buy
+5,738
New +$236K 0.02% 419

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Regal Investment Advisors's GMAB Position: Q2 2024 in Review

Regal Investment Advisors sold out of Genmab (GMAB) in Q2 2024, closing a stake of 6,863 shares — an estimated $205K sold.

Regal Investment Advisors first reported a position in GMAB in Q4 2022 and held it in 3 quarters. The position peaked at $243K in Q4 2022. 219 funds tracked by Wall St. Rank hold GMAB as of Q2 2024.

  • Regal Investment Advisors reported no remaining Genmab position as of Q2 2024 after selling out during the quarter.
  • Regal Investment Advisors sold 6,863 Genmab shares in Q2 2024, an estimated $205K.
  • Regal Investment Advisors first reported a position in Genmab in Q4 2022 and held it in 3 quarters.
  • Regal Investment Advisors's Genmab position peaked at $243K in Q4 2022.
  • 219 funds tracked by Wall St. Rank held Genmab as of Q2 2024.

Based on Regal Investment Advisors's 13F filing for Q2 2024, filed 15 Aug 2024.